Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter June 9, 2015

An ethnopharmacological approach to the preliminary screening of native Australian herbal medicines for anticancer activity

  • Aaron C. Tan , Izabela Konczak , George Li , Basil D. Roufogalis , Bhagwant Sekhon and Daniel M.-Y. Sze EMAIL logo

Abstract

Background: Five plants used traditionally by Australian Aboriginals and two edible native Australian fruits have been investigated for anticancer activity. The aim was to identify native Australian herbal medicines which displayed anticancer activity, with cytotoxicity to cancer cells but sparing or even proliferating normal immunological cells, and subsequently provide potentially new anticancer drug leads.

Methods: Extracts and derived fractions were assayed for cell viability against a multiple myeloma cell line, RPMI-8226, in comparison to the peripheral blood mononuclear cells (PBMC) representing normal human immunological cells.

Results: None of the crude extracts exhibited the desirable differential activity; however, following further fractionation of the Eremophila duttonii F. Muell. (Myoporaceae) extract, one fraction (termed F01) exhibited a greater cytotoxicity to the cancer cell line than to the normal cells.

Conclusions: One fraction may potentially contain valuable compounds which may be useful for further investigation. This may focus on the identification of the bioavailable purified compounds present within these fractions or by detailed delineation of the related mechanisms of action.

Acknowledgments

The authors would like to thank the Traditional Aboriginal Owners of the Australian land. The authors would like to thank the Cancer Institute NSW Fellowship for support of this study (DMS). The authors would also like to thank the staff and students in the Faculty of Pharmacy, The University of Sydney, especially Meng Qiuxia and Iyad Ahmed.

Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

Research funding: None declared.

Employment or leadership: None declared.

Honorarium: None declared.

Competing interests: The funding organization(s)played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. ButlerMS. The role of natural product chemistry in drug discovery. J Nat Prod2004;67:214153.10.1021/np040106ySearch in Google Scholar PubMed

2. FabricantDS, FarnsworthNR. The value of plants used in traditional medicine for drug discovery. Environ Health Perspect2001;109:6975.10.1289/ehp.01109s169Search in Google Scholar PubMed PubMed Central

3. IsaacsJ. Bush food: aboriginal food and herbal medicine. McMahons Point, NSW: Weldons, 1987.Search in Google Scholar

4. TanAC, KonczakI, RamzanI, SzeDM. Native Australian fruit polyphenols inhibit cell viability and induce apoptosis in human cancer cell lines. Nutr Cancer2011;63:44455.10.1080/01635581.2011.535953Search in Google Scholar PubMed

5. TanAC, SzeDM. Indigenous herbs and cancer. J Complement Med2008;7:4850.Search in Google Scholar

6. HeywoodVH. Ethnopharmacology, food production, nutrition and biodiversity conservation: towards a sustainable future for indigenous peoples. J Ethnopharmacol2011;137:115.10.1016/j.jep.2011.05.027Search in Google Scholar PubMed

7. LowT. Bush medicine: a pharmacopoeia of natural extracts. North Ryde, NSW: Angus & Robertson, 2000.Search in Google Scholar

8. LassakEV, McCarthyT. Australian medicinal plants. Kew, Victoria: Reed, 2001.Search in Google Scholar

9. KonczakI, ZabarasD, XiaoD, ShapiraD, LeeG. Anti-proliferative and pro-apoptotic activity of Illawarra plum. J Clin Biochem Nutr2008;43:5437.Search in Google Scholar

10. BrusottiG, CesariI, DentamaroA, CaccialanzaG, MassoliniG. Isolation and characterization of bioactive compounds from plant resources: the role of analysis in the ethnopharmacological approach. J Pharm Biomed Anal2014;87:21828.10.1016/j.jpba.2013.03.007Search in Google Scholar PubMed

11. ButterweckV, NahrstedtA. What is the best strategy for preclinical testing of botanicals? A critical perspective. Planta Med2012;78:74754.10.1055/s-0031-1298434Search in Google Scholar PubMed

12. SmithJE, TuckerD, WatsonK, JonesGL. Identification of antibacterial constituents from the indigenous Australian medicinal plant Eremophila duttonii F Muell. (Myoporaceae). J Ethnopharmacol2007;112:38693.10.1016/j.jep.2007.03.031Search in Google Scholar PubMed

13. BarrA, KnightT, AlexanderV, AndrewsM. Traditional bush medicines: an aboriginal pharmacopoeia. Richmond, Victoria: Greenhouse Publications, 1998.Search in Google Scholar

14. TanAC, KonczakI, SzeDM, RamzanI. Towards the discovery of novel phytochemicals for disease prevention from native Australian plants: an ethnobotanical approach. Asia Pac J Clin Nutr2010;19:3304.Search in Google Scholar

15. SekhonBK, RoubinRH, TanA, ChanWK, SzeDM. High-throughput screening platform for anticancer therapeutic drug cytotoxicity. Assay Drug Dev Technol2008;6:71121.10.1089/adt.2008.148Search in Google Scholar PubMed

Received: 2014-3-27
Accepted: 2015-5-18
Published Online: 2015-6-9
Published in Print: 2015-9-1

©2015 by De Gruyter

Downloaded on 23.9.2023 from https://www.degruyter.com/document/doi/10.1515/jcim-2014-0017/html
Scroll to top button